Skip to main content
Industry News
US secures nearly all remdesivir for next 3 months

HHS has said the US has purchased 500,000 treatment courses of Gilead Sciences' antiviral drug remdesivir, which includes all doses produced in July and 90% of production in August and September. HHS Secretary Alex Azar touted the agreement, but experts raised concerns about the US outbidding other countries instead of working collaboratively to manage access to remdesivir and other drugs or vaccines that may show promise.

Full Story: